Work

Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-132065

Authors: Eric Huselton, Amanda F Cashen, John F. DiPersio, Meagan Jacoby, Iskra Pusic, Rizwan Romee, Mark A. Schroeder, Geoffrey L. Uy, Peter Westervelt

Institutions: University of Rochester Medicine, Washington University in St. Louis, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2982810237

Cites:

Cited by: 8

Related to: 10